Request Deal Involvement
Novo Holdings, OrbiMed, and F-Prime Capital led a $100 million Series A financing round in OnCusp Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
target
ONCUSP THERAPEUTICS
bidder
NOVO HOLDINGS A/S
bidder
ORBIMED ADVISORS LLC
bidder
CATALIO CAPITAL MANAGEMENT
bidder
FORGE LIFE SCIENCE PARTNERS
bidder
BIOTRACK CAPITAL
bidder
F-PRIME CAPITAL
bidder
SOFINNOVA INVESTMENTS
bidder
MARSHALL WACE
bidder
BLACKBIRD BIOVENTURES
bidder
CJNV BIOVENTURE
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite